Us Pharma
- All
- News
- Videos
-
With 2024 In Mind, Joe Biden's Big Move To Lower Drug Prices
US President Joe Biden, who is campaigning for reelection with a heavy focus on easing voters' financial woes, on Tuesday launched a bid to lower the cost of certain prescription drugs -- a move Big Pharma pledged to continue battling in court.
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
"Of Standard Quality": Government Sources On Eye Drop Flagged By US Body
The samples of eye drops made by Chennai-based Global Pharma Healthcare - linked to three deaths and blindness in the US, are of "standard quality", sources in the Health Ministry told NDTV today.
-
"No Contamination Found": Tamil Nadu Official As US Flags Indian Eye Drop
Tamil Nadu's drug regulator has said it found "no contamination" in samples of eye drops manufactured by Chennai-based Global Pharma, which has hit headlines after a US watchdog linked cases of infections, blindness and even deaths to the eye drops.
-
US Concerned Over Spread Of Drug-Resistant Germ Tied To Indian Eyedrops: Report
The top medical watchdog in the US has raised concerns over the likelihood of a highly drug-resistant bacteria, linked to eyedrops made by an Indian company, gaining a foothold in the US.
-
Gujarat Pharma Firm Recalls Over 55,000 Medicine Bottles From US Market
The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.
-
Alembic Pharma Gets Regulator's Approval To Market Antidepressant Drug In US
Alembic Pharmaceuticals has received an approval from the US Food & Drug Administration to market Brexpiprazole tablets in strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg.
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
Drug Regulatory Body Takes Samples Of Eye Drops Linked To Death In US
Members of Tamil Nadu's Drug Controller and Central Drug Control Authority conducted a late-night inspection of manufacturing premises of Global Pharma Healthcare Private Limited.
-
Late-Night Inspection At Chennai Firm Linked To Vision Loss, Death In US
Global Pharma Healthcare, the drug manufacturer at the centre of the controversy, has said it's working closely with the US Food and Drug Administration (FDA).
-
Indian Firm Suspends Production Of Eye Drops Linked To Death In US
The US Centers for Disease Control and Prevention (CDC) said it is testing unopened bottles of EzriCare Artificial Tears eye drops, manufactured by Chennai-based Global Pharma Healthcare.
-
"Drug Products Adulterated": US Regulator Warns Sun Pharma's Gujarat Plant
The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant.
-
Sun Pharma Says Gujarat Facility Listed Under US Regulator's Import Alert
The import alert means all future shipments of products made at Halol can be refused admission to the US market until the facility becomes compliant with the FDA's Current Good Manufacturing Practice standards,
-
Aurobindo Pharma Recalls Products In US Market For Manufacturing Lapses
Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator.
-
Dr Reddy's, Cipla, Aurobindo Units Recall Products From US Market
Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration.
-
With 2024 In Mind, Joe Biden's Big Move To Lower Drug Prices
US President Joe Biden, who is campaigning for reelection with a heavy focus on easing voters' financial woes, on Tuesday launched a bid to lower the cost of certain prescription drugs -- a move Big Pharma pledged to continue battling in court.
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
"Of Standard Quality": Government Sources On Eye Drop Flagged By US Body
The samples of eye drops made by Chennai-based Global Pharma Healthcare - linked to three deaths and blindness in the US, are of "standard quality", sources in the Health Ministry told NDTV today.
-
"No Contamination Found": Tamil Nadu Official As US Flags Indian Eye Drop
Tamil Nadu's drug regulator has said it found "no contamination" in samples of eye drops manufactured by Chennai-based Global Pharma, which has hit headlines after a US watchdog linked cases of infections, blindness and even deaths to the eye drops.
-
US Concerned Over Spread Of Drug-Resistant Germ Tied To Indian Eyedrops: Report
The top medical watchdog in the US has raised concerns over the likelihood of a highly drug-resistant bacteria, linked to eyedrops made by an Indian company, gaining a foothold in the US.
-
Gujarat Pharma Firm Recalls Over 55,000 Medicine Bottles From US Market
The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.
-
Alembic Pharma Gets Regulator's Approval To Market Antidepressant Drug In US
Alembic Pharmaceuticals has received an approval from the US Food & Drug Administration to market Brexpiprazole tablets in strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg.
-
Sun Pharma Recalls Over 34,000 Bottles Of Generic Drug In US After It Fails Test
Drug major Sun Pharma is recalling over 34,000 bottles of a generic medication, used to treat high blood pressure, in the US market due to failed dissolution testing.
-
Drug Regulatory Body Takes Samples Of Eye Drops Linked To Death In US
Members of Tamil Nadu's Drug Controller and Central Drug Control Authority conducted a late-night inspection of manufacturing premises of Global Pharma Healthcare Private Limited.
-
Late-Night Inspection At Chennai Firm Linked To Vision Loss, Death In US
Global Pharma Healthcare, the drug manufacturer at the centre of the controversy, has said it's working closely with the US Food and Drug Administration (FDA).
-
Indian Firm Suspends Production Of Eye Drops Linked To Death In US
The US Centers for Disease Control and Prevention (CDC) said it is testing unopened bottles of EzriCare Artificial Tears eye drops, manufactured by Chennai-based Global Pharma Healthcare.
-
"Drug Products Adulterated": US Regulator Warns Sun Pharma's Gujarat Plant
The US health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of drug products, at its Gujarat-based plant.
-
Sun Pharma Says Gujarat Facility Listed Under US Regulator's Import Alert
The import alert means all future shipments of products made at Halol can be refused admission to the US market until the facility becomes compliant with the FDA's Current Good Manufacturing Practice standards,
-
Aurobindo Pharma Recalls Products In US Market For Manufacturing Lapses
Aurobindo Pharma units are recalling different products in the US market for manufacturing lapses, as per the US health regulator.
-
Dr Reddy's, Cipla, Aurobindo Units Recall Products From US Market
Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration.
